Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ostarine moves into phase II development for muscle wasting

Sep. 13, 2005

Novel PTP-1B inhibitor synthesized by Incyte

Sep. 13, 2005

Rotigaptide: potential as a therapy for osteoporosis

Sep. 13, 2005

FDA advisory committee votes to recommend Pargluva for type 2 diabetes

Sep. 12, 2005

Astellas Pharma discloses novel therapeutic agents for bone disorders

Sep. 12, 2005

Exubera recommended for approval

Sep. 12, 2005

Novel SARMs developed by Bristol-Myers Squibb

Sep. 12, 2005

Tesaglitazar reduces the incidence of metabolic syndrome in hypertriglyceridemic patients

Sep. 12, 2005

Swiss approval for once-monthly Bonviva

Sep. 9, 2005

GSK-171B: A novel MC4R agonist

Sep. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...